Allergic-Like Reactions Occur in Pre-Medicated Patients

Key points
- Allergic-like reactions can occur in patients (both children and adults) when given gadolinium containing contrast agents, even if they have been pre-medicated with corticosteroids and antihistamines, according to a recent study conducted by researchers at the University of Michigan Health Systems in Ann Arbor.
- “We pre-medicate patients at our institution who have a history of prior allergic-like reaction to gadolinium-containing contrast agents”, said Jonathan R.
- The researchers reviewed contrast material reaction forms from the institution’s department of radiology over a five-year period.
- Of these reactions, six were mild and three were moderate.
Allergic-like reactions can occur in patients (both children and adults) when given gadolinium containing contrast agents, even if they have been pre-medicated with corticosteroids and antihistamines, according to a recent study conducted by researchers at the University of Michigan Health Systems in Ann Arbor.
“We pre-medicate patients at our institution who have a history of prior allergic-like reaction to gadolinium-containing contrast agents”, said Jonathan R. Dillman, MD, lead author of the study. “Pre-medication is sometimes also considered in patients who have a history of prior severe allergic-like reaction to another substance (including iodinated contrast material),” said Dr. Dillman. “While we know from previous studies that allergic-like reactions may occur following pre-medication in the setting of repeat iodinated contrast material injections (the so-called ‘breakthrough reaction’), we were uncertain if this phenomenon also occurred in the setting of repeat gadolinium-containing contrast material administration,” he said.
The researchers reviewed contrast material reaction forms from the institution’s department of radiology over a five-year period. According to the study, eight patients experienced nine allergic-like reactions (one patient experienced two breakthrough reactions) after being administered a gadolinium-containing contrast agent despite being pre-medicated.
Of these reactions, six were mild and three were moderate. There were no severe or fatal breakthrough reactions. All patients who experienced breakthrough reactions had a history of allergic-like reactions to either gadolinium or iodine containing contrast media.
“While we believe that pre-medication likely decreases an individual’s risk of allergic-like reaction to gadolinium-containing contrast material, our study concludes that ‘breakthrough reactions’ do occur. Radiologists, therefore, must be available to treat an allergic-like reaction following gadolinium-containing contrast material administration, even when a patient has been pre-medicated with corticosteroids and antihistamines,” said Dr. Dillman.
The full results of this study appear in a recent issue of the American Journal of Roentgenology.
Source: American Roentgen Ray Society (ARRS)
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Lungs, Asthma & Allergies →
NewsCystic fibrosis patients of low SES are less likely to be accepted for lung transplant
Adult cystic fibrosis (CF) patients of low socioeconomic status (SES) have a greater chance of not being accepted for lung transplant after undergoing initial evaluation, according to a new study. "While earlier studies…
14 September 2012
NewsWhy Hot, Humid Air Triggers Symptoms in Patients with Mild Asthma
May is asthma awareness month, and with summer right around the corner, a study shows that doctors may be closer to understanding why patients with mild asthma have such difficulty breathing during hot, humid weather.…
7 June 2012
NewsResearchers identify new regulator in allergic diseases
Researchers have taken a critical step in understanding how allergic reactions occur after identifying a genetic signature for regulation of a key immune hormone, interleukin (IL-13). Scientists from Cincinnati…